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Ilioinguinal lymph node dissection in the management of lower limb
malignant melanoma: Current guidelines and practiceIt is estimated that 20–40 per cent of patients with lower limb
malignant melanoma associated with palpable inguinal lymph
nodes, will have occultmetastases of the pelvic lymph nodes.1 There
is current debate regarding the appropriate management of lymph
nodes following lower limb melanoma, with opinions varying as to
when an inguinal lymph node dissection should be extended to
also include the pelvic nodes. Reluctancy to perform the extended
dissectionmay stem fromconcerns of potentially signiﬁcant postop-
erative morbidity2 and surgical unfamiliarity of a relatively
uncommon procedure, with little evidence of long-term beneﬁt.
To date there has been a paucity of literature on this topic and an
absence of national guidelines until only very recently,3 despite the
clinical impact on skin cancer patientmanagement. It was therefore
the aim of this study to elucidate current practice in our national
plastic surgery service and shed some light on this previously over-
looked but critically important area of patient care.
All 53 plastic surgery units in the UK were sent a postal ques-
tionnaire which enquired about the characteristics of the unit’s
management of lower limb malignant melanoma (Table 1).
Data was received from 32 consultant plastic surgeons who
perform routine melanoma surgery. The mean number of inguinal
node dissections being performed per year for malignant mela-
noma of the lower limb is 10.1 (8.1) and the mean number of
ilioinguinal lymph node dissections (ILND) is 1.5 (1.8).
Our study cohort were asked about various indications for ILND
(and were permitted to select one or more answers in multiple
choice format). 78% of consultant plastic surgeons selected iliac
nodal involvement on scan as a reason. Conversely, only 28% carry
out ILND if palpable inguinal nodes are present. Consultant plastic
surgeons also used positive sentinel lymph node biopsy in the
pelvis (19%) and the presence of metastatic disease in the node of
Cloquet (9%), as an indication for ILND. In groin disease recurrence,Table 1
Areas of enquiry during the structured survey.
(1) The number of inguinal dissections for melanoma that are performed
each year in the unit.
(2) The number of ilioinguinal dissections for melanoma that are performed
each year in the unit.
(3) In what circumstances ilioinguinal node dissection is performed.
(4) How frequently the assistance of a surgical colleague is sought for
ilioinguinal dissection.
(5) Which surgical approach is utilised for ilioinguinal node dissection.
Table 2
Indications for ilioinguinal lymph node dissection.
Indication for ilioinguinal dissection Percentage of UK consultant plastic
surgeons in study cohort who
selected indication
Iliac nodal involvement on scan 78
Palpable inguinal nodes 28
Positive sentinel lymph node biopsy 19
Groin disease recurrence 13
Metastatic disease in node of Cloquet 91743-9191/$ – see front matter  2011 Surgical Associates Ltd. Published by Elsevier Lt
doi:10.1016/j.ijsu.2011.06.00413% of our study cohort dissect the pelvic nodes in addition to the
inguinal nodes (Table 2). Critically, 9% of plastic surgeons do not
dissect pelvic nodes under any circumstances. According to
recently published guidance, pelvic dissection should be consid-
ered if more than one inguinal, femoral or pelvic node is detected
clinically or radiologically, if more than one node has microscopic
disease at sentinel node biopsy, if a conglomerate of inguinal or
femoral nodes is present, or if Cloquet’s node is micro- or macro-
scopically involved.3
When questioned regarding intraoperative assistance from
other surgical colleagues, 31% of consultant plastic surgeons never
require help, however 19% always have general surgical input. 6% of
respondents always receive assistance from a plastic surgery
colleague. Almost half of our study cohort only occasionally request
the input of a surgical colleague (47%), whether a general (31%),
plastic (9%), urological (3%), or vascular surgeon (3%).
Splitting the inguinal ligament versus making a separate iliac
fossa incision are equally popular surgical approaches to removing
the pelvic nodes, with 41% of consultants opting for each of these
methods. The remaining 18% employed various other surgical tech-
niques. Surgical approach was also determined by assessing the
size and location of the primary melanoma and selecting the
most appropriate therapeutic option on a case by case basis.
The data indicates that, up to the time of the recent publication
of national guidelines, opinions and practices varied greatly
amongst the respondents. Furthermore it is evident that some
consultant plastic surgeons are not conﬁdent to undertake ILND
independently, although this latter point may well change with
recent moves towards dedicated ‘skin cancer specialists’. We
endeavour to review current UK practice in a year’s time, to assess
the impact of the national guidelines on routine practice. Thed. All rights reserved.
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a universal evidence-based approach when dealing with lower
limb melanoma associated with lymph node metastases.
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